Quantum BioPharma Peer Comparison
$2.24
$-0.02
(-0.88%)
As on 03-Nov-2026 15:16EST
Market cap
$15 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
2.4
Div. Yield
0 %
Edit
| Quantum BioPharma | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
15 | 3,069 | 1,216 | 645 | 304 |
Revenue ($ Mln) |
-- | 11,084 | 225 | 182 | 920 |
Net Profit ($ Mln) |
-24.89 | -841.00 | 69.79 | 153.05 | -58.67 |
Net Margin (%) |
-- | -7.59 | 30.98 | 84.23 | -6.38 |
RoE (%) |
-333.30 | -- | 5.60 | 91.29 | -5.59 |
Price to Earnings |
-- | -- | 17.37 | 5.33 | -- |
Price-To-Book |
2.43 | 18.78 | 1.14 | 3.23 | 0.42 |
Cashflow ($ Mln)
| Quantum BioPharma | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-8.38 | 1,400.00 | 26.32 | -39.64 | 70.92 |
|
Cash Flow from Investing Activities
|
-1.99 | -595.00 | -77.90 | 15.58 | 17.45 |
|
Cash from Financing Activities
|
6.21 | -742.00 | -20.25 | 5.72 | -54.49 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Quantum BioPharma | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-248.22 | 0.76 | -0.89 | -36.37 | -1.23 |
|
ROE (%)
|
-333.30 | -17.14 | 5.60 | 91.29 | -5.59 |
|
ROA (%)
|
-97.21 | -4.45 | 5.70 | 79.37 | -4.31 |
|
EBIT Margin (%)
|
-- | 11.19 | -1.28 | 84.27 | -1.16 |
|
Net Margin (%)
|
-- | -7.59 | 30.98 | 84.23 | -6.38 |
|
Cash Profit Margin (%)
|
-- | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Quantum BioPharma | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-- | 10.52 | 72.88 | 1,078.78 | -3.33 |
|
EBIT Growth (%)
|
11.62 | -41.29 | 92.87 | 367.23 | 88.29 |
|
Net Profit Growth (%)
|
7.88 | -332.32 | 277.46 | 382.12 | 36.42 |
|
EPS Growth (%)
|
71.83 | -272.48 | 281.14 | 374.07 | 32.91 |
|
Book Value Growth (%)
|
-4.18 | -258.65 | -1.26 | 203.81 | -3.91 |
Valuation Ratios
| Quantum BioPharma | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-1.08 | 16.40 | -105.42 | -27.51 | -27.71 |
|
Price / Book Value
|
4.11 | -4.66 | 0.93 | 12.04 | 0.40 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-0.93 | 7.07 | -54.50 | -25.25 | 6.96 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Quantum BioPharma | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | -14.89 | 0.00 | 0.00 | 0.00 |
|
Short term debt to equity ratio
|
0.12 | 0.00 | 0.00 | 0.00 | 0.04 |
|
Current Ratio
|
1.20 | 23.44 | 16.18 | 81.42 | 3.92 |
|
Quick Ratio
|
1.19 | 18.41 | 15.25 | 81.42 | 2.34 |
|
Interest Coverage
|
-53.83 | 0.78 | -- | 2,014.87 | -8.99 |
Operating Efficiency Ratios
| Quantum BioPharma | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Arbutus Biopharma Corp (ABUS) | Sundial Growers - ADR | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
-- | 22.85 | 23.12 | 98.91 | 3.80 |
|
Asset Turnover
|
0.00 | 0.59 | 0.18 | 0.94 | 0.68 |
|
Receivable days
|
-- | 79.82 | 106.48 | 53.89 | 11.30 |
|
Inventory Days
|
55.67 | 195.23 | 166.85 | -- | 68.84 |
|
Payable days
|
1,722.12 | 76.06 | 59.75 | 1,755.31 | 14.63 |
|
Cash Conversion Cycle
|
-- | 198.99 | 213.59 | -- | 65.51 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
